BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 34659112)

  • 1. Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.
    Aranda G; Halperin I; Gomez-Gil E; Hanzu FA; SeguĂ­ N; Guillamon A; Mora M
    Front Endocrinol (Lausanne); 2021; 12():718200. PubMed ID: 34659112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
    Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
    Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
    J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
    J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
    Ong C; Monita M; Liu M
    Climacteric; 2024 Jun; 27(3):227-235. PubMed ID: 38597210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.
    Hashemi L; Marijic Buljubasic A; Budoff MJ; Copeland LA; Jackson NJ; Jasuja GK; Gornbein J; Reue K
    JAMA Netw Open; 2024 Jul; 7(7):e2419696. PubMed ID: 38954413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy.
    Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC
    Eur J Prev Cardiol; 2022 Nov; 29(15):2017-2026. PubMed ID: 35778824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy.
    Dix C; Moloney M; Tran HA; McFadyen JD
    Thromb Haemost; 2024 May; 124(5):387-398. PubMed ID: 37816389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
    Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
    Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
    Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
    Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
    Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
    Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
    LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of Gender-Affirming Hormone Therapy Requirements.
    Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
    LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender Identity, Hormone Therapy, and Cardiovascular Disease Risk.
    Martinez C; Rikhi R; Haque T; Fazal A; Kolber M; Hurwitz BE; Schneiderman N; Brown TT
    Curr Probl Cardiol; 2020 May; 45(5):100396. PubMed ID: 30340769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internalized transphobia predicts worse longitudinal trend of body uneasiness in transgender persons treated with gender affirming hormone therapy: a 1-year follow-up study.
    Castellini G; Rossi E; Cassioli E; Sanfilippo G; Ristori J; Vignozzi L; Maggi M; Ricca V; Fisher AD
    J Sex Med; 2023 Feb; 20(3):388-397. PubMed ID: 36763949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
    Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
    Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.